Skip to main content
All lobbying clients

GENENTECH, INC.

Lobbying client · California · filed 2025 to 2026

Biotech company developing medicines to treat patients.

$24,140,000 Reported spend
108 Filings counted
15 Outside firms hired
14 Bills named

Spend is reported income plus in-house expenses across 108 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 16 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as GENENTECH, GENENTECH INC.

 Who filed for this client 16

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 14
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    11 filings
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    7 filings
  • S. 1040
    Drug Competition Enhancement Act
    4 filings
  • S. 1041
    Affordable Prescriptions for Patients Act
    4 filings
  • H. Con. Res. 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    3 filings
  • H.R. 3269
    ETHIC Act
    3 filings
  • H.R. 7148
    Consolidated Appropriations Act, 2026
    3 filings
  • S. Con. Res. 7
    An original concurrent resolution setting forth the congressional budget for the United States Government for…
    3 filings
  • H.R. 9504
    Tax Exempt Hospital Transparency Act
    2 filings
  • H.R. 9599
    SECURE 340B Act
    2 filings
  • H.R. 2882
    Further Consolidated Appropriations Act, 2024
    1 filing
  • H.R. 1
    One Big Beautiful Bill Act
    1 filing
  • H.R. 1672
    Maintaining Investments in New Innovation Act
    1 filing
  • H.R. 3599
    Joint Reserve Detachment (JRD) Formalization Act
    1 filing
 Reported by year 2 years
  • 2026 $10,700,000 46 filings
  • 2025 $13,440,000 62 filings
 Issues lobbied 10

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 11
  • HOUSE OF REPRESENTATIVES 99
  • SENATE 85
  • Health & Human Services, Dept of (HHS) 27
  • Centers For Medicare and Medicaid Services (CMS) 15
  • Food & Drug Administration (FDA) 14
  • U.S. Trade Representative (USTR) 8
  • Homeland Security, Dept of (DHS) 7
  • Labor, Dept of (DOL) 7
  • Patent & Trademark Office (PTO) 7
  • Treasury, Dept of 7
  • White House Office 7
 Recent filings 109 total
Q3 report
HARBINGER STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 21, 2026
View →
Q3 report
YC CONSULTING, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $50,000 income · posted Oct 20, 2026
View →
Q3 report
MARSHALL & POPP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
KING & SPALDING LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · $20,000 income · posted Oct 20, 2026
View →
Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View →
Q3 report
AKIN GUMP STRAUSS HAUER & FELD
3rd Quarter 2026 (July 1 - Sep 30) · House · $50,000 income · posted Oct 20, 2026
View →
Q3 report
FARRAGUT PARTNERS LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
THE MCMANUS GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
FORBES-TATE
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
CAPITOL COUNSEL LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 reportNo activity
TIBER CREEK HEALTH STRATEGIES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · $60,000 income · posted Oct 19, 2026
View →
Q3 report
GENENTECH, INC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $2,890,000 expenses · posted Oct 19, 2026
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q3 report
OGR
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 17, 2026
View →
Q3 report
CORNERSTONE GOVERNMENT AFFAIRS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 8, 2026
View →
Q2 report
HARBINGER STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 21, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
KING & SPALDING LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · $20,000 income · posted Jul 20, 2026
View →
Q2 report
FORBES-TATE
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 109 filings. Search the explorer for "GENENTECH, INC.".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem